Home Exercise Beats Cancer Cardio Risk Using Cardiac Rehab Playbook
A meta-analysis of 9 trials finds home-based cardiac rehab improves fitness and quality of life in cancer patients with 75%+ adherence.
Resumen
Cancer treatments damage the heart, leaving patients at elevated cardiovascular risk. This systematic review and meta-analysis pooled data from nine randomized controlled trials (632 participants) testing home-based exercise programs modeled on cardiac rehabilitation principles. Results showed meaningful improvements in cardiorespiratory fitness and health-related quality of life, with adherence exceeding 75% in most studies and a dropout rate of just 15.2%. No clear safety signals emerged, though adverse-event reporting was inconsistent across trials. The findings suggest that structured home exercise — combining aerobic and resistance training aligned with cardiac rehab guidelines — is a feasible, accessible alternative or complement to center-based programs for cancer patients who face barriers to in-person care.
Resumen detallado
Cancer and cardiovascular disease are increasingly intertwined. Chemotherapy, radiation, and targeted therapies can cause significant cardiotoxicity, and many cancer patients share lifestyle risk factors with heart disease patients. This dual burden makes cardiac rehabilitation — a structured program of supervised exercise and lifestyle support — a logical intervention for oncology patients, yet access to center-based programs remains limited by geography, fatigue, and treatment schedules.
This systematic review and meta-analysis addressed that gap by evaluating home-based exercise interventions that follow established cardiac rehabilitation principles. Researchers searched six major databases and identified nine randomized controlled trials enrolling 632 adults with cancer. Eligible programs included structured aerobic and/or resistance exercise consistent with cardiac rehab guidelines. Primary outcomes were cardiorespiratory fitness (CRF), health-related quality of life (HRQoL), adherence, and safety.
The pooled results were encouraging. Home-based cardiac rehab produced a moderate improvement in cardiorespiratory fitness (SMD 0.42; 95% CI 0.09–0.75) and a larger improvement in health-related quality of life (SMD 0.63; 95% CI 0.05–1.22). Adherence exceeded 75% in most reporting studies, and the overall dropout rate was 15.2% — comparable to or better than many center-based programs. Methodological quality was generally good, with mean TESTEX scores of 10 out of 15.
However, findings for muscle strength and fatigue were inconsistent across trials, and adverse-event reporting was incomplete, making firm safety conclusions impossible. The high heterogeneity in HRQoL results (I²=84%) also warrants caution in interpreting effect sizes.
For longevity-focused practitioners, these findings highlight the practical value of integrating cardiac rehab frameworks into cancer survivorship care. Home delivery dramatically expands access. Future research should test comprehensive, multi-component cardiac rehab models — including psychological and nutritional support — specifically designed for oncology populations.
Hallazgos clave
- Home-based cardiac rehab improved cardiorespiratory fitness with a moderate effect size (SMD 0.42) across 9 RCTs.
- Health-related quality of life improved significantly (SMD 0.63), though heterogeneity was high (I²=84%).
- Adherence exceeded 75% in most studies; overall dropout rate was 15.2%, indicating strong feasibility.
- No clear safety signals emerged, but inconsistent adverse-event reporting prevents firm conclusions.
- Strength and fatigue outcomes showed inconsistent results, highlighting gaps needing further study.
Metodología
Systematic review and meta-analysis of 9 RCTs (632 participants) identified from six databases searched through January 2025. Interventions required structured aerobic and/or resistance exercise consistent with cardiac rehab guidelines; random-effects meta-analyses calculated standardized mean differences. Methodological quality was assessed using the TESTEX scale.
Limitaciones del estudio
Only nine small RCTs (632 total participants) were included, limiting statistical power and generalizability. Adverse-event reporting was inconsistent across trials, preventing reliable safety conclusions. High heterogeneity in quality-of-life outcomes (I²=84%) and inconsistent strength and fatigue findings suggest variability in program design, cancer types, and populations studied.
¿Te ha gustado este resumen?
Recibe la última investigación sobre longevidad en tu bandeja de entrada cada semana.
Introduce tu correo electrónico para suscribirte: